Modern Enterprise and Standalone Cheminformatics Solutions

presentation · 7 years ago
by David Deng (ChemAxon)
Fragment-based drug discovery (FBDD) has become the mainstream of pharmaceutical and biotech research since relevant practical technology allows the detection the weak interaction between a fragment and the target. A generally accepted roadmap is now available to guide fragment-to-lead evolution when structural information is available. Here we describe a sample roadmap facilitated by cheminformatics approaches developed by ChemAxon. Download slides